Capture

PRODUCTS

  • Manipulator machines can process a wide range of different containers such as vials, cartridges, and prefilled syringes, either bulk or nested, in order to meet the current pharmaceutical industry requirements and to address the end users' needs. They are designed to ensure the integrity of high-value products such as biotechnology, nuclear, cytotoxic, and more, or to treat different containers with a single machine thanks to the use of manipulator robots. These machines can be customized by joining our professional skills in filling and inspection applications and users' requirements.

  • ​AqueoUS Vets offers a technically superior line of products for various treatment requirements. These advanced technology products include filtration equipment as well as industry leading ion exchange resins and granular activated carbons (GAC). 

  • Elplasia Plates

    Enable high density, scaffold-free, self-assembly spheroid formation, culture, and analysis in a standard plate footprint.

    With the effectiveness of 3D spheroids in many areas of research including anti-cancer drug screening and in vitro tumor studies, the need for better methods to produce replicate spheroids of uniform size in mass quantities has emerged.

    Corning Elplasia plates address this need by enabling researchers to generate a high density of spheroids in a scaffold-free model using microcavity technology. Use Corning Elplasia plates to generate, culture, and analyze hundreds to thousands of spheroids all in a standard plate footprint. Corning Elplasia plates are available in multiple formats, two well geometry types, and two surface coatings.

  • Scaling your drug product from concept to commercial supply requires having the expertise to ask the right questions about your end goals, from the start.

  • Navigating both the specific country and general European regulations and requirements to supply medicinal products to the European markets can be a complex challenge. This applies both to Marketing Authorisation Holders (MAH) of approved commercial medicinal products and Sponsors of clinical trials.

WHITE PAPERS AND CASE STUDIES

NEWS